Prelude Therapeutics (PRLD) Cash & Current Investments (2019 - 2026)
Prelude Therapeutics (PRLD) recorded Cash & Current Investments of $280.63 million in Q2 2026, up 263.2% from $77.26 million a year earlier and up 94.1% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Prelude Therapeutics reported Cash & Current Investments of $106.45 million, down 22.7% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -13.4% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $137.66 million in FY2024 (-41.9%), $236.98 million in FY2023 (+15.2%), $205.77 million in FY2022 (-30.3%) and $295.28 million in FY2021 (+35.3%).
- The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q4 2021.
- On a year-over-year basis, Cash & Current Investments rose in two of the last eight quarters, with growth averaging 5.0%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 263.2% in Q2 2026, against a decline of 58.4% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $144.6 million (Q1 2026), $106.45 million (Q4 2025) and $65.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Prelude Therapeutics | 292.88 Mn | -304.42 Mn | - | 280.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 280.63 Mn |
| Mar 31, 2026 | 144.60 Mn |
| Dec 31, 2025 | 106.45 Mn |
| Sep 30, 2025 | 65.63 Mn |
| Jun 30, 2025 | 77.26 Mn |
| Mar 31, 2025 | 103.12 Mn |
| Dec 31, 2024 | 137.66 Mn |
| Sep 30, 2024 | 157.67 Mn |
| Jun 30, 2024 | 183.89 Mn |
| Mar 31, 2024 | 205.97 Mn |
| Dec 31, 2023 | 236.98 Mn |
| Sep 30, 2023 | 234.55 Mn |
| Jun 30, 2023 | 259.03 Mn |
| Mar 31, 2023 | 176.30 Mn |
| Dec 31, 2022 | 205.77 Mn |
| Sep 30, 2022 | 228.09 Mn |
| Jun 30, 2022 | 250.35 Mn |
| Mar 31, 2022 | 270.23 Mn |
| Dec 31, 2021 | 295.28 Mn |
| Sep 30, 2021 | 320.87 Mn |
API Access
Prelude Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();